BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33676073)

  • 1. Cannabidiol (CBD) and other drug use among young adults who use cannabis in Los Angeles.
    Fedorova EV; Wong CF; Ataiants J; Iverson E; Conn BM; Lankenau SE
    Drug Alcohol Depend; 2021 Apr; 221():108648. PubMed ID: 33676073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition.
    Arkell TR; Lintzeris N; Kevin RC; Ramaekers JG; Vandrey R; Irwin C; Haber PS; McGregor IS
    Psychopharmacology (Berl); 2019 Sep; 236(9):2713-2724. PubMed ID: 31044290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
    Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study.
    Trevitt BT; Bailey S; Mills L; Arkell TR; Suraev A; McGregor IS; Lintzeris N
    PLoS One; 2024; 19(2):e0297092. PubMed ID: 38354169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cannabidiol in cannabis flower: Implications for harm reduction.
    Gibson LP; Karoly HC; Ellingson JM; Klawitter J; Sempio C; Squeri JE; Bryan AD; Bidwell LC; Hutchison KE
    Addict Biol; 2022 Jan; 27(1):e13092. PubMed ID: 34467598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabidiol attenuates the appetitive effects of Delta 9-tetrahydrocannabinol in humans smoking their chosen cannabis.
    Morgan CJ; Freeman TP; Schafer GL; Curran HV
    Neuropsychopharmacology; 2010 Aug; 35(9):1879-85. PubMed ID: 20428110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and correlates of cannabidiol product and marijuana co-use in a sample of U.S. young adults.
    Dunbar MS; Seelam R; Tucker JS; Firth CL; Pedersen ER; Klein DJ; Rodriguez A; D'Amico EJ
    Addict Behav; 2022 Mar; 126():107185. PubMed ID: 34839070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 10. The acute effects of cannabis with and without cannabidiol in adults and adolescents: A randomised, double-blind, placebo-controlled, crossover experiment.
    Lawn W; Trinci K; Mokrysz C; Borissova A; Ofori S; Petrilli K; Bloomfield M; Haniff ZR; Hall D; Fernandez-Vinson N; Wang S; Englund A; Chesney E; Wall MB; Freeman TP; Curran HV
    Addiction; 2023 Jul; 118(7):1282-1294. PubMed ID: 36750134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population.
    Highet BH; Lesser ER; Johnson PW; Kaur JS
    Am J Hosp Palliat Care; 2020 Aug; 37(8):589-593. PubMed ID: 31986898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use and Perceptions of Cannabidiol Products in Canada and in the United States.
    Goodman S; Wadsworth E; Schauer G; Hammond D
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):355-364. PubMed ID: 33998872
    [No Abstract]   [Full Text] [Related]  

  • 13. Cannabinoid Exposure and Subjective Effects of THC and CBD in Edible Cannabis Products.
    Gibson LP; Mueller RL; Winiger EA; Klawitter J; Sempio C; Williams S; Bryan AD; Bidwell LC; Hutchison KE
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):320-334. PubMed ID: 36378267
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance: A Randomized Clinical Trial.
    Arkell TR; Vinckenbosch F; Kevin RC; Theunissen EL; McGregor IS; Ramaekers JG
    JAMA; 2020 Dec; 324(21):2177-2186. PubMed ID: 33258890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illicit drug use and prescription drug misuse among young adult medical cannabis patients and non-patient users in Los Angeles.
    Fedorova EV; Schrager SM; Robinson LF; Cepeda A; Wong CF; Iverson E; Lankenau SE
    Drug Alcohol Depend; 2019 May; 198():21-27. PubMed ID: 30861391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being.
    Morgan CJ; Gardener C; Schafer G; Swan S; Demarchi C; Freeman TP; Warrington P; Rupasinghe I; Ramoutar A; Tan N; Wingham G; Lewis S; Curran HV
    Psychol Med; 2012 Feb; 42(2):391-400. PubMed ID: 21798112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable effects of cannabis with and without cannabidiol on the human brain's resting-state functional connectivity.
    Wall MB; Pope R; Freeman TP; Kowalczyk OS; Demetriou L; Mokrysz C; Hindocha C; Lawn W; Bloomfield MA; Freeman AM; Feilding A; Nutt D; Curran HV
    J Psychopharmacol; 2019 Jul; 33(7):822-830. PubMed ID: 31013455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal Actions of the Cannabis Constituents Δ(9)-Tetrahydrocannabinol and Cannabidiol in a Mouse Neuropathic Pain Model.
    Casey SL; Mitchell VA; Sokolaj EE; Winters BL; Vaughan CW
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Consequences of Adolescent Exposure to THC-Rich/CBD-Poor and CBD-Rich/THC-Poor Combinations: A Comparison with Pure THC Treatment in Female Rats.
    Gabaglio M; Zamberletti E; Manenti C; Parolaro D; Rubino T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.